Verified earnings results
Citius Oncology Q3 2026 Earnings Results
Direct answer
Citius Oncology reported Q3 2026 results on August 14, 2026.
Revenue was 1,494,000. EPS beat the estimate by 1.96%.
The result is verified against Verified earnings source.
Verified earnings source
Get free Citius Oncology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Earnings date
- August 14, 2026
- Reported timing
- After the US market closes
- EPS estimate
- -0.0816
- Reported EPS
- -0.08
- Revenue
- 1,494,000
- EPS surprise
- EPS beat the estimate by 1.96%.
Explore related company data
Read the frequently asked questions.
When did Citius Oncology report Q3 2026 earnings?
Citius Oncology reported on August 14, 2026. The reported timing was after the us market closes.
What is the available EPS estimate for Citius Oncology?
The verified record provides an EPS estimate of -0.0816.
Has Citius Oncology reported the Q3 2026 result?
Revenue was 1,494,000. EPS beat the estimate by 1.96%.
Which source supports this Citius Oncology earnings record?
The earnings record identifies Verified earnings source as its source. Missing values are not estimated.